Absci (ABSI) Cash from Operations (2020 - 2026)
Absci's (ABSI) quarterly Cash from Operations came in at 26307000.0 in Q1 2026, down 20.46% year-on-year from 33073431.18 in Q1 2025, and up 9.85% quarter-over-quarter from 29182000.0 in Q4 2025.
Absci (ABSI) Cash from Operations (2020 - 2026) Analysis & Trends
Absci has disclosed Cash from Operations across 7 years of filings, most recently posting 26307000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 26307000.0, down 20.46% year-over-year; the trailing twelve-month figure through Mar 2026 was 97393000.0 (down 27.51% YoY), and the FY2025 annual result was 92925000.0, down 28.35% from the prior year.
- Cash from Operations came in at 26307000.0 for Q1 2026 at Absci, up from 29182000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 10361000.0 in Q3 2023 to a low of 29182000.0 in Q4 2025.
- The 5-year median for Cash from Operations is 19234000.0 (2023), against an average of 19859352.94.
- Across the five-year window, Cash from Operations slumped 190.31% in 2022 and soared 45.59% in 2023, its largest moves.
- Absci's Cash from Operations stood at 18568000.0 in 2022, then advanced by 19.64% to 14922000.0 in 2023, then decreased by 13.68% to 16964000.0 in 2024, then slumped by 72.02% to 29182000.0 in 2025, then climbed by 9.85% to 26307000.0 in 2026.
- The last three Cash from Operations figures came in at 26307000.0 (Q1 2026), 29182000.0 (Q4 2025), and 25031000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -26.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.31 Mn |
| Mar 31, 2026 | -26.31 Mn |
| Dec 31, 2025 | -29.18 Mn |
| Dec 31, 2025 | -29.18 Mn |
| Sep 30, 2025 | -25.03 Mn |
| Sep 30, 2025 | -25.03 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Mar 31, 2025 | -21.84 Mn |
| Mar 31, 2025 | -21.84 Mn |
| Dec 31, 2024 | -16.96 Mn |
| Dec 31, 2024 | -16.96 Mn |
| Sep 30, 2024 | -20.73 Mn |
| Sep 30, 2024 | -20.73 Mn |
| Jun 30, 2024 | -16.84 Mn |
| Jun 30, 2024 | -16.84 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Dec 31, 2023 | -14.92 Mn |
| Dec 31, 2023 | -14.92 Mn |